Somatropine ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	1

78. Hypopituitarism

Clinical trials : 492 / Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00476385 (ClinicalTrials.gov)	June 2003	21/5/2007	Practicability and Acceptability of Stylomax® in Children	Usability and Acceptability of Stylomax® in Growth Hormone Deficient Children.	Growth Hormone Deficiency	Drug: somatropine	Sanofi	NULL	Completed	3 Years	18 Years	Both	12	Phase 3	France